Follow-The-Filings

Security · featured owners

WHWK Aadi Bioscience Inc.

Health Care COM Equity among managers we track

WHWK (Aadi Bioscience Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 10 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02,9.01
8-K 2.02,9.01
10-Q
8-K 5.07
8-K 8.01,9.01
8-K 1.01,3.02,7.01,9.01
8-K 2.02,9.01
10-Q
DEFA14A
10-K

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Sep 15, 2026 · 5 forms
4 Period Sep 9, 2026
4 Period May 14, 2026
4 Period Jun 12, 2026 · 7 forms
4 Period May 14, 2026 · 5 forms
4 Period May 12, 2026
4 Period Apr 15, 2026
4 Period Apr 13, 2026
4 Period Apr 9, 2026
4 Period Apr 9, 2026
4 Period Apr 6, 2026

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $24.35M $25.98M $7.14M
Gross profit * $21.54M $22.96M $6.38M
Gross margin * 88.5% 88.4% 89.4%
Net income -$65.76M -$63.69M -$20.6M
Net margin * -270.0% -245.1% -288.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $124.59M $61.29M $149.01M
Total non-current assets * $7.84M $9.03M $1.82M
Total assets $132.42M $70.32M $150.83M
Total current liabilities $26.4M $17.07M $14.52M
Total non-current liabilities * $833,000 $767,000 $0.00
Total equity $105.2M $52.48M $136.31M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$59.66M -$59.55M -$97.43M
Cash from investing $83.21M $25.2M $11.89M
Cash from financing $0.326M $0.13M $94.38M
Net change in cash $23.87M -$34.22M $8.83M

ownership over time

filing count by report period · click a bar for that quarter’s holders